PSELANE CONEY: Open Payments
NPI 1558660043 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,940 in 43 payments from 17 companies in 2025. Trend: 2023 $502 · 2024 $578 · 2025 $1,940
Food & beverage: $993Long term medical supply or device loan: $897Education: $50
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $1,040 |
| Janssen Biotech, Inc. | 4 | $340 |
| AstraZeneca Pharmaceuticals LP | 3 | $69 |
| Tempus AI, Inc | 3 | $67 |
| Lilly USA, LLC | 3 | $59 |
| SEAGEN INC. | 1 | $50 |
| Caris MPI, Inc. | 1 | $46 |
| Legend Biotech USA Inc. | 1 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34 |
Products named: KISQALI, RYBREVANT, ENHERTU, XT CDX, VERZENIO, SCEMBLIX, MI CANCER SEEK, TALVEY.
Industry payments across FL — which companies pay providers there.
